-
Thermo Fisher and Catalent to manufacture gene therapies being developed by Amicus
fiercepharma
July 04, 2019
Amicus Therapeutics has already forked over $100 million for 10 gene therapies. It is building a new R&D operation to advance them. But when it comes to manufacturing, it is turning to CDMOs.
-
Thermo Fisher receives reimbursement coverage for Oncomine test
biospectrumasia
June 05, 2019
As an approved CDx system, Oncomine Dx Target Test can now be applied upfront at the initial diagnostic treatment stage for all NSCLC patients in Japan.
-
Thermo Fisher to acquire GSK API Site for €90 M
biospectrumasia
May 20, 2019
Expands global footprint for complex API manufacturing
-
Thermo Fisher, Genovis Advance Bio-Characterization and Monitoring Methods
contractpharma
April 09, 2019
Thermo Fisher, Genovis Advance Bio-Characterization and Monitoring Methods
-
Thermo Fisher showcases clinical analytical solutions at MSACL US 2019
biospectrumasia
April 03, 2019
Thermo Fisher Scientific announces the expansion of its portfolio of analytical instruments for clinical diagnostic ……
-
Thermo Fisher buys Brammer Bio for $1.7bn
pharmatimes
March 27, 2019
Thermo Fisher, another life sciences group pitching in on the future of gene therapy, has announced plans to enter into a definitive agreement to acquire Brammer Bio for approximately $1.7 billion.
-
Thermo Fisher shoulders into gene therapy manufacturing with $1.7B deal for Brammer
firstwordpharma
March 25, 2019
With gene therapies becoming a hot growth area, CDMOs are figuring out how to get a bigger piece of the market. Thermo Fisher Scientific decided to buy its way in, agreeing to pay $1.7 billion to get viral vector producer Brammer Bio.
-
Thermo Fisher to acquire viral vector manufacturing firm
biospectrumasia
March 25, 2019
Significantly expands capabilities to support high-growth gene and cell therapy market
-
Thermo Fisher brings new automated sampling solution for VOC analysis
biospectrumasia
March 20, 2019
The Thermo Scientific TriPlus 500 Gas Chromatography Headspace Autosampler is designed for high sample throughput and low cost-per-sample for routine Volatile Organic Compounds (VOCs) analysis by pharmaceutical, food safety and environmental scientists.
-
Thermo Fisher to invest $150 M in expanding pharma services
biospectrumasia
March 19, 2019
Expansion projects will increase capacity to meet growing customer demand for biologics